These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 28258898)

  • 21. Multicriteria optimization enables less experienced planners to efficiently produce high quality treatment plans in head and neck cancer radiotherapy.
    Kierkels RG; Visser R; Bijl HP; Langendijk JA; van 't Veld AA; Steenbakkers RJ; Korevaar EW
    Radiat Oncol; 2015 Apr; 10():87. PubMed ID: 25885444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methodology for analysis and reporting patterns of failure in the Era of IMRT: head and neck cancer applications.
    Mohamed AS; Rosenthal DI; Awan MJ; Garden AS; Kocak-Uzel E; Belal AM; El-Gowily AG; Phan J; Beadle BM; Gunn GB; Fuller CD
    Radiat Oncol; 2016 Jul; 11(1):95. PubMed ID: 27460585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using a novel dose QA tool to quantify the impact of systematic errors otherwise undetected by conventional QA methods: clinical head and neck case studies.
    Chan MF; Li J; Schupak K; Burman C
    Technol Cancer Res Treat; 2014 Feb; 13(1):57-67. PubMed ID: 23819494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing 3DCRT and inversely optimized IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window techniques.
    Longobardi B; De Martin E; Fiorino C; Dell'oca I; Broggi S; Cattaneo GM; Calandrino R
    Radiother Oncol; 2005 Nov; 77(2):148-56. PubMed ID: 16260056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiation therapy planning for early-stage Hodgkin lymphoma: experience of the International Lymphoma Radiation Oncology Group.
    Maraldo MV; Dabaja BS; Filippi AR; Illidge T; Tsang R; Ricardi U; Petersen PM; Schut DA; Garcia J; Headley J; Parent A; Guibord B; Ragona R; Specht L
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):144-52. PubMed ID: 25670544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Auto-segmentation of low-risk clinical target volume for head and neck radiation therapy.
    Yang J; Beadle BM; Garden AS; Gunn B; Rosenthal D; Ang K; Frank S; Williamson R; Balter P; Court L; Dong L
    Pract Radiat Oncol; 2014; 4(1):e31-7. PubMed ID: 24621429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre Phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer.
    Clark CH; Miles EA; Urbano MT; Bhide SA; Bidmead AM; Harrington KJ; Nutting CM;
    Br J Radiol; 2009 Jul; 82(979):585-94. PubMed ID: 19332518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of loco-regional failures in head and neck cancer after radical radiation therapy.
    De Felice F; Thomas C; Barrington S; Pathmanathan A; Lei M; Urbano TG
    Oral Oncol; 2015 Nov; 51(11):1051-1055. PubMed ID: 26506048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective nodal irradiation for head and neck cancer using intensity-modulated radiotherapy: application of RTOG consensus guidelines in routine clinical practice.
    Nangia S; Chufal KS; Tyagi A; Bhatnagar A; Mishra M; Ghosh D
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):146-53. PubMed ID: 19553034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Multi-Institutional Prospective Peer Review on Target and Organ-at-Risk Delineation in Radiation Therapy.
    Riegel AC; Vaccarelli M; Cox BW; Chou H; Cao Y; Potters L
    Pract Radiat Oncol; 2019 Mar; 9(2):e228-e235. PubMed ID: 30415075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer.
    Hansen EK; Bucci MK; Quivey JM; Weinberg V; Xia P
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):355-62. PubMed ID: 16256277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Target volume selection and delineation (T and N) for primary radiation treatment of oral cavity, oropharyngeal, hypopharyngeal and laryngeal squamous cell carcinoma.
    Grégoire V; Grau C; Lapeyre M; Maingon P
    Oral Oncol; 2018 Dec; 87():131-137. PubMed ID: 30527228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinically relevant quality assurance for intensity modulated radiotherapy plans: gamma maps and DVH-based evaluation.
    Caivano R; Califano G; Fiorentino A; Cozzolino M; Oliviero C; Pedicini P; Clemente S; Chiumento C; Fusco V
    Cancer Invest; 2014 Mar; 32(3):85-91. PubMed ID: 24499109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical introduction of a linac head-mounted 2D detector array based quality assurance system in head and neck IMRT.
    Korevaar EW; Wauben DJ; van der Hulst PC; Langendijk JA; Van't Veld AA
    Radiother Oncol; 2011 Sep; 100(3):446-52. PubMed ID: 21963288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality assurance needs for modern image-based radiotherapy: recommendations from 2007 interorganizational symposium on "quality assurance of radiation therapy: challenges of advanced technology".
    Williamson JF; Dunscombe PB; Sharpe MB; Thomadsen BR; Purdy JA; Deye JA
    Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S2-12. PubMed ID: 18406928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosimetric evaluation of automatic segmentation for adaptive IMRT for head-and-neck cancer.
    Tsuji SY; Hwang A; Weinberg V; Yom SS; Quivey JM; Xia P
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):707-14. PubMed ID: 20231063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Landmark-based auto-contouring of clinical target volumes for radiotherapy of nasopharyngeal cancer.
    Sjogreen C; Netherton TJ; Lee A; Soliman M; Gay SS; Nguyen C; Mumme R; Vazquez I; Rhee DJ; Cardenas CE; Martel MK; Beadle BM; Court LE
    J Appl Clin Med Phys; 2024 Sep; 25(9):e14474. PubMed ID: 39074490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of DVH-based treatment plan verification in addition to gamma passing rates for head and neck IMRT.
    Visser R; Wauben DJ; de Groot M; Steenbakkers RJ; Bijl HP; Godart J; van't Veld AA; Langendijk JA; Korevaar EW
    Radiother Oncol; 2014 Sep; 112(3):389-95. PubMed ID: 25154319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality assurance assessment of diagnostic and radiation therapy-simulation CT image registration for head and neck radiation therapy: anatomic region of interest-based comparison of rigid and deformable algorithms.
    Mohamed AS; Ruangskul MN; Awan MJ; Baron CA; Kalpathy-Cramer J; Castillo R; Castillo E; Guerrero TM; Kocak-Uzel E; Yang J; Court LE; Kantor ME; Gunn GB; Colen RR; Frank SJ; Garden AS; Rosenthal DI; Fuller CD
    Radiology; 2015 Mar; 274(3):752-63. PubMed ID: 25380454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. To propose adding index of achievement (IOA) to IMRT QA process.
    Kim DS; Kim S; Kang SH; Kim TH; Park SH; Kim KH; Cho MS; Shin DS; Noh YY; Chung JB; Suh TS
    Radiat Oncol; 2018 Jun; 13(1):112. PubMed ID: 29903025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.